Showing results (141-150 of 447) with videos related to
Sort By:
Pageof 45
Journal of Translational Medicine|November 3, 2010
Detection of carcinoembryonic antigen messenger RNA in blood using quantitative real-time reverse transcriptase-polymerase chain reaction to predict recurrence of gastric adenocarcinomaMiao-Zhen Qiu, Zhuang-Hua Li, Zhi-Wei Zhou, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 4, 2010
Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to irinotecan combination chemotherapyXin An, Pei-Rong Ding, Xiao-Juan Xiang, et al.Journal of Hematology & Oncology|July 21, 2026
Clinical benefit of PD-1 antibody plus chemotherapy in advanced HER2 negative gastric or gastro-oesophageal junction adenocarcinoma according to PD-L1 levels: Post-hoc analysis of RATIONALE-305 and pooled analysis of individual patient-level dataMing-Yu Lai, Hao-Xiang Wu, Ming-Ming He, et al.Therapeutic Advances in Medical Oncology|November 16, 2020
Practical considerations in the use of regorafenib in metastatic colorectal cancerFotios Loupakis, Lorenzo Antonuzzo, Jean-Baptiste Bachet, et al.Plos One|August 23, 2012
Are risk factors associated with outcomes in pancreatic cancer?De-shen Wang, Zhi-qiang Wang, Le Zhang, et al.Theranostics|May 17, 2021
Erratum: Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis: ErratumXiao-Peng Tian, Chen-Yuan Wang, Xiao-Han Jin, et al.Science Bulletin|February 6, 2024
Modulator of TMB-associated immune infiltration (MOTIF) predicts immunotherapy response and guides combination therapyZheng-Yu Qian, Yi-Qian Pan, Xue-Xin Li, et al.Journal of Cancer|February 28, 2018
Elevated baseline serum lactate dehydrogenase indicates a poor prognosis in primary duodenum adenocarcinoma patientsZhan-Hong Chen, Miao-Zhen Qiu, Xiang-Yuan Wu, et al.Theranostics|May 1, 2019
Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and MetastasisXiao-Peng Tian, Chen-Yuan Wang, Xiao-Han Jin, et al.Clinical Pharmacokinetics|August 14, 2025
Clinical Pharmacology Profile of the Claudin 18.2 Antibody ZolbetuximabJianning Yang, Akihiro Yamada, Kohei Shitara, et al.Pageof 45